Genprex Inc. (NASDAQ:GNPX)

There are currently no videos for this stock.
To request coverage of this stock, please click the green request video box on the right.
Bands Volume 200 SMA 50 SMA 20 SMA Videos Alerts Articles Events
GNPX Weekly Chart

Old Forum Content for GNPX

Make a Forum Post
Become a member to view recent forum posts. Already a member? Sign in here.
Loading...
  • sierramp: $GNPX pullback, bounce. Refinitiv/Verus upgraded yesterday from Hold to Buy. 1min VWAP has been good support this afternoon. Will add if it decides to stay above the 8EMA.
  • issues: Comparing IBD group 3 biotechs $GNPX $NTGN $NVAX $SMMT $APTO: I like $NVAX best and bought 1/2 position. Also bought 250 shares (starter position) on SMMT with stop at $1.90. This is a good risk/reward! Lots to gain, not much to risk.
  • geotheo: #IPOs- IPOs expected to price: Vioma Technology ($VIOT) on September 24; Capital Bancorp ($CBNK), Entasis Therapeutics ($ETTX), SVMK ($SVMK), Arco Platform ($ARCE) and CooTek Cayman ($CTK) on September 25; Sutro Biopharma ($STRO), RA Medical Systems ($RMED), LAIX ($LAIX), Urovant Sciences ($UROV) and Arvinas ($ARVN) on September 26; Gristone Oncology ($GRTS) on September 27 IPO lockup expirations: GreenTree Hospitality (NYSE:$GHG), OP Bancorp (NASDAQ:$OPBK), Homology Medicines (NASDAQ:$FIXX), Bilibili (NASDAQ:$BILI) and OneSmart Internet Education (NYSE:$ONE) on September 24; Iqiyi (NASDAQ:$IQ) Unum Therapeutics (NASDAQ:$UMRX) and Genprex (NASDAQ:$GNPX) on September 25.
  • Max115: $GNPX Would be nice to have a few of these :)
Visit the Trading Forum to join in the discussion.
Stock Price $10.92
Change -5.04%
Volume 292,643

Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.

Request Video of GNPX
Already a member? Sign in here.
Past Month

Leading Peers

Past Month

Lagging Peers

Dan Fitzpatrick

Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:

  • Nightly video Strategy Sessions with a game plan for tomorrow
  • Got a stock you want Dan to look at? Just ask.
  • Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
  • Access to over 90,400 stock analysis videos
  • Access an ever expanding library (90,400) of educational videos that will save you time and make you money

Join a team of friends and traders that have one thing in common; a burning desire to succeed.

Become a Member Today!

Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...

Satisfaction Guaranteed!

Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!